Modification of L-DOPA metabolism: Benefits and problems

被引：1
|
作者：
Brooks, David J. [1 ]
机构：
[1] Imperial Coll Sch Med, Div Neurosci, Fac Med, London, England
来源：
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2008年 / 34卷 / 01期
关键词：
D O I：
10.1016/j.ejps.2008.02.016
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [1] PROBLEMS WITH L-DOPA THERAPY
    CALNE, DB
    REID, JL
    VAKIL, SD
    PALLIS, C
    CLINICAL MEDICINE/US, 1971, 78 (02): : 21 - +
  • [2] WILSONS DISEASE - MODIFICATION BY L-DOPA
    GELMERS, HJ
    TROOST, J
    WILLEMSE, J
    NEUROPADIATRIE, 1973, 4 (04): : 453 - 457
  • [3] ALTERED PHARMACOKINETICS OF L-DOPA METABOLISM
    MELAMED, E
    HEFTI, F
    NEUROLOGY, 1985, 35 (06) : 939 - 940
  • [4] L-DOPA AND MITOCHONDRIAL METABOLISM IN FIBROBLASTS
    WERNER, P
    COHEN, G
    MYTILINEOU, C
    JOURNAL OF NEUROCHEMISTRY, 1994, 62 : S106 - S106
  • [5] MODIFICATION OF PARKINSONISM - CHRONIC TREATMENT WITH L-DOPA
    COTZIAS, GC
    PAPAVASI.PS
    GELLENE, R
    NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (07): : 337 - &
  • [6] METABOLISM OF D-DOPA VS L-DOPA - REPLY
    SANDLER, M
    KAROUM, F
    RUTHVEN, CRJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1970, 282 (14): : 813 - &
  • [7] L-DOPA ABSORPTION AND METABOLISM BY HUMAN STOMACH
    RIVERACA.L
    DUJOVNE, C
    MORGAN, J
    LASAGNA, L
    BIANCHIN.J
    PHARMACOLOGIST, 1970, 12 (02): : 269 - &
  • [8] METABOLISM OF ORALLY ADMINISTERED L-DOPA IN PARKINSONISM
    CALNE, DB
    KAROUM, F
    RUTHVEN, CRJ
    SANDLER, M
    BRITISH JOURNAL OF PHARMACOLOGY, 1969, 37 (01) : 57 - +
  • [9] ALTERED PHARMACOKINETICS OF L-DOPA METABOLISM - REPLY
    WOOTEN, GF
    SPENCER, SE
    NEUROLOGY, 1985, 35 (06) : 940 - 941
  • [10] L-DOPA ABSORPTION AND METABOLISM BY HUMAN STOMACH
    BIANCHINE, J
    RIVERACA.L
    DUJOVNE, C
    MORGAN, J
    LASAGNA, L
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1971, 5 (05): : 147 - +
12345